vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Climb Global Solutions, Inc. (CLMB). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $182.4M, roughly 1.3× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -35.0%, a 36.9% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs -23.6%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
CCRN vs CLMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $236.8M | $182.4M |
| Net Profit | $-82.9M | $3.3M |
| Gross Margin | — | 14.5% |
| Operating Margin | -30.2% | 2.1% |
| Net Margin | -35.0% | 1.8% |
| Revenue YoY | -23.6% | 32.1% |
| Net Profit YoY | -2109.7% | -9.5% |
| EPS (diluted) | $-2.56 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $182.4M | ||
| Q4 25 | $236.8M | $193.8M | ||
| Q3 25 | $250.1M | $161.3M | ||
| Q2 25 | $274.1M | $159.3M | ||
| Q1 25 | $293.4M | $138.0M | ||
| Q4 24 | $309.9M | $161.8M | ||
| Q3 24 | $315.1M | $119.3M | ||
| Q2 24 | $339.8M | $92.1M |
| Q1 26 | — | $3.3M | ||
| Q4 25 | $-82.9M | $7.0M | ||
| Q3 25 | $-4.8M | $4.7M | ||
| Q2 25 | $-6.7M | $6.0M | ||
| Q1 25 | $-490.0K | $3.7M | ||
| Q4 24 | $-3.8M | $7.0M | ||
| Q3 24 | $2.6M | $5.5M | ||
| Q2 24 | $-16.1M | $3.4M |
| Q1 26 | — | 14.5% | ||
| Q4 25 | — | 15.4% | ||
| Q3 25 | 20.4% | 15.9% | ||
| Q2 25 | 20.4% | 16.5% | ||
| Q1 25 | 20.0% | 16.9% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | 20.4% | 20.3% | ||
| Q2 24 | 20.8% | 20.2% |
| Q1 26 | — | 2.1% | ||
| Q4 25 | -30.2% | 4.9% | ||
| Q3 25 | -2.4% | 4.3% | ||
| Q2 25 | -2.1% | 5.0% | ||
| Q1 25 | -0.3% | 3.5% | ||
| Q4 24 | -1.1% | 7.2% | ||
| Q3 24 | 0.9% | 7.1% | ||
| Q2 24 | -5.7% | 4.6% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | -35.0% | 3.6% | ||
| Q3 25 | -1.9% | 2.9% | ||
| Q2 25 | -2.4% | 3.7% | ||
| Q1 25 | -0.2% | 2.7% | ||
| Q4 24 | -1.2% | 4.3% | ||
| Q3 24 | 0.8% | 4.6% | ||
| Q2 24 | -4.7% | 3.7% |
| Q1 26 | — | $0.18 | ||
| Q4 25 | $-2.56 | $1.51 | ||
| Q3 25 | $-0.15 | $1.02 | ||
| Q2 25 | $-0.20 | $1.30 | ||
| Q1 25 | $-0.02 | $0.81 | ||
| Q4 24 | $-0.13 | $1.52 | ||
| Q3 24 | $0.08 | $1.19 | ||
| Q2 24 | $-0.47 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $41.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $118.4M |
| Total Assets | $449.0M | $458.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $41.8M | ||
| Q4 25 | $108.7M | $36.6M | ||
| Q3 25 | $99.1M | $49.8M | ||
| Q2 25 | $81.2M | $28.6M | ||
| Q1 25 | $80.7M | $32.5M | ||
| Q4 24 | $81.6M | $29.8M | ||
| Q3 24 | $64.0M | $22.1M | ||
| Q2 24 | $69.6M | $48.4M |
| Q1 26 | — | $118.4M | ||
| Q4 25 | $322.8M | $116.6M | ||
| Q3 25 | $408.1M | $109.3M | ||
| Q2 25 | $412.2M | $105.2M | ||
| Q1 25 | $418.2M | $95.6M | ||
| Q4 24 | $419.0M | $90.6M | ||
| Q3 24 | $424.7M | $87.7M | ||
| Q2 24 | $433.3M | $79.8M |
| Q1 26 | — | $458.8M | ||
| Q4 25 | $449.0M | $460.2M | ||
| Q3 25 | $538.2M | $376.1M | ||
| Q2 25 | $553.8M | $420.7M | ||
| Q1 25 | $576.2M | $370.1M | ||
| Q4 24 | $589.3M | $469.2M | ||
| Q3 24 | $597.4M | $371.9M | ||
| Q2 24 | $602.9M | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $-11.9M | ||
| Q3 25 | $20.1M | $22.2M | ||
| Q2 25 | $4.2M | $-2.2M | ||
| Q1 25 | $5.7M | $8.5M | ||
| Q4 24 | $24.2M | $16.0M | ||
| Q3 24 | $7.5M | $-3.6M | ||
| Q2 24 | $82.4M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -1.70× | ||
| Q3 25 | — | 4.73× | ||
| Q2 25 | — | -0.37× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | 2.92× | -0.66× | ||
| Q2 24 | — | 2.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
CLMB
Segment breakdown not available.